{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:37:42Z","timestamp":1775695062314,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012797","name":"NorthShore University HealthSystem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genome-wide association studies have identified thousands of disease-associated single nucleotide polymorphisms (SNPs). A subset of these SNPs may be additively combined to generate genetic risk scores (GRSs) that confer risk for a specific disease. Although the clinical validity of GRSs to predict risk of specific diseases has been well established, there is still a great need to determine their clinical utility by applying GRSs in primary care for cancer risk assessment and targeted intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This clinical study involved 281 primary care patients without a personal history of breast, prostate or colorectal cancer who were 40\u201370\u00a0years old. DNA was obtained from a pre-existing biobank at NorthShore University HealthSystem. GRSs for colorectal cancer and breast or prostate cancer were calculated and shared with participants through their primary care provider. Additional data was gathered using questionnaires as well as electronic medical record information. A t-test or Chi-square test was applied for comparison of demographic and key clinical variables among different groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age of the 281 participants was 58\u00a0years and the majority were female (66.6%). One hundred one (36.9%) participants received 2 low risk scores, 99 (35.2%) received 1 low risk and 1 average risk score, 37 (13.2%) received 1 low risk and 1 high risk score, 23 (8.2%) received 2 average risk scores, 21 (7.5%) received 1 average risk and 1 high risk score, and no one received 2 high risk scores. Before receiving GRSs, younger patients and women reported significantly more worry about risk of developing cancer. After receiving GRSs, those who received at least one high GRS reported significantly more worry about developing cancer. There were no significant differences found between gender, age, or GRS with regards to participants\u2019 reported optimism about their future health neither before nor after receiving GRS results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Genetic risk scores that quantify an individual\u2019s risk of developing breast, prostate and colorectal cancers as compared with a race-defined population average risk have potential clinical utility as a tool for risk stratification and to guide cancer screening in a primary care setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-020-02699-w","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T01:02:58Z","timestamp":1611277378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessing the clinical utility of genetic risk scores for targeted cancer screening"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-7004","authenticated-orcid":false,"given":"Carly A.","family":"Conran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Kyle","family":"Resurreccion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Genova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqun Lilly","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Brendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"issue":"24","key":"2699_CR1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879\u201386. https:\/\/doi.org\/10.1093\/jnci\/81.24.1879.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2699_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors [published correction appears in Stat Med. 2005 Jan 15;24(1):156]. Stat Med. 2004;23(7):1111\u201330. https:\/\/doi.org\/10.1002\/sim.1668.","journal-title":"Stat Med"},{"issue":"18","key":"2699_CR3","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for prostate cancer: US preventive services task force recommendation statement [published correction appears in JAMA. 2018 Jun 19;319(23):2443]. JAMA. 2018;319(18):1901\u201313. https:\/\/doi.org\/10.1001\/jama.2018.3710.","journal-title":"JAMA"},{"issue":"23","key":"2699_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2016.5989","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(23):2564\u201375. https:\/\/doi.org\/10.1001\/jama.2016.5989.","journal-title":"JAMA"},{"issue":"1","key":"2699_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104(1):21\u201334. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.002.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2699_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2017.74.1173","volume":"36","author":"VN Giri","year":"2018","unstructured":"Giri VN, Knudsen KE, Kelly WK, et al. Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018;36(4):414\u201324. https:\/\/doi.org\/10.1200\/JCO.2017.74.1173.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2699_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1373\/clinchem.2018.286658","volume":"65","author":"RJ Fantus","year":"2019","unstructured":"Fantus RJ, Helfand BT. Germline genetics of prostate cancer: time to incorporate genetics into early detection tools. Clin Chem. 2019;65(1):74\u20139. https:\/\/doi.org\/10.1373\/clinchem.2018.286658.","journal-title":"Clin Chem"},{"issue":"3","key":"2699_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/annonc\/mdv540","volume":"27","author":"MJ Frampton","year":"2016","unstructured":"Frampton MJ, Law P, Litchfield K, et al. Implications of polygenic risk for personalised colorectal cancer screening. Ann Oncol. 2016;27(3):429\u201334. https:\/\/doi.org\/10.1093\/annonc\/mdv540.","journal-title":"Ann Oncol"},{"key":"2699_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/CLEP.S145636","volume":"10","author":"K Weigl","year":"2018","unstructured":"Weigl K, Chang-Claude J, Knebel P, Hsu L, Hoffmeister M, Brenner H. Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score. Clin Epidemiol. 2018;10:143\u201352. https:\/\/doi.org\/10.2147\/CLEP.S145636.","journal-title":"Clin Epidemiol"},{"issue":"23","key":"2699_CR10","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1158\/1078-0432.CCR-18-0370","volume":"24","author":"L Barber","year":"2018","unstructured":"Barber L, Gerke T, Markt SC, et al. Family history of breast or prostate cancer and prostate cancer risk. Clin Cancer Res. 2018;24(23):5910\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0370.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2699_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","volume":"165","author":"HR Brewer","year":"2017","unstructured":"Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017;165(1):193\u2013200. https:\/\/doi.org\/10.1007\/s10549-017-4325-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2699_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/0969141319842331","volume":"26","author":"V Charlotte","year":"2019","unstructured":"Charlotte V, Sandro S, Rachael D. Cancer worry frequency vs. intensity and self-reported colorectal cancer screening uptake: a population-based study. J Med Screen. 2019;26(4):169\u201378.","journal-title":"J Med Screen"},{"issue":"4","key":"2699_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1158\/1055-9965.EPI-05-0629","volume":"15","author":"A McQueen","year":"2006","unstructured":"McQueen A, Vernon S, Meissner H. Are there gender differences in colorectal cancer test use prevalence and corralates? Cancer Epidemiol Biomarkers Prev. 2006;15(4):782\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2699_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0005-7967(90)90135-6","volume":"28","author":"TJ Meyer","year":"1990","unstructured":"Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry questionnaire. Behav Res Ther. 1990;28:487\u201395.","journal-title":"Behav Res Ther"},{"issue":"6","key":"2699_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/1359105316679721","volume":"23","author":"E Choi","year":"2018","unstructured":"Choi E, et al. Associations of perceived risk and cancer worry for colorectal cancer with screening behaviour. J Health Psychol. 2018;23(6):840\u201352. https:\/\/doi.org\/10.1177\/1359105316679721.","journal-title":"J Health Psychol"},{"issue":"11","key":"2699_CR16","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/pon.5211","volume":"28","author":"Z Xie","year":"2019","unstructured":"Xie Z, Wenger N, Stanton L. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: a single-arm trial of personalized risk communication. Psychooncology. 2019;28(11):2226\u201332. https:\/\/doi.org\/10.1002\/pon.5211.","journal-title":"Psychooncology"},{"issue":"4","key":"2699_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/NCC.0000000000000511","volume":"41","author":"A Caruso","year":"2018","unstructured":"Caruso A, Vigna C, Gremigni P. The cancer worry scale revised for breast cancer genetic counseling. Cancer Nurs. 2018;41(4):311\u20139. https:\/\/doi.org\/10.1097\/NCC.0000000000000511.","journal-title":"Cancer Nurs"},{"issue":"1","key":"2699_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10689-018-0082-6","volume":"18","author":"C Whitney","year":"2019","unstructured":"Whitney C, Dorfman C, Shelby R. Reminders of cancer risk and pain catastrophizing: relationships with cancer worry and perceived risk in women with a first-degree relative with breast cancer. Fam Cancer. 2019;18(1):9\u201318. https:\/\/doi.org\/10.1007\/s10689-018-0082-6.","journal-title":"Fam Cancer"},{"key":"2699_CR19","unstructured":"SEER Cancer Stat Facts: Female Breast Cancer. National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"issue":"12","key":"2699_CR20","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41395-018-0075-y","volume":"113","author":"MCS Wong","year":"2018","unstructured":"Wong MCS, Chan CH, Lin J, et al. Lower relative contribution of positive family history to colorectal cancer risk with increasing age: a systematic review and meta-analysis of 9.28 million individuals. Am J Gastroenterol. 2018;113(12):1819\u201327.","journal-title":"Am J Gastroenterol."},{"issue":"13","key":"2699_CR21","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1016\/j.cgh.2019.09.007","volume":"17","author":"VH Roos","year":"2019","unstructured":"Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, et al. Effects of family history on relative and absolute risks for colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(13):2657-2667.e9.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2699_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jnci\/djj131","volume":"98","author":"IM Thompson","year":"2006","unstructured":"Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006;98(8):529\u201334.","journal-title":"J Natl Cancer Inst"},{"key":"2699_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2796.2011.02504.x","volume":"272","author":"JA Thomas 2nd","year":"2012","unstructured":"Thomas JA 2nd, Gerber L, Moreira DM, et al. Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1). J Intern Med. 2012;272:85\u201392.","journal-title":"J Intern Med"},{"issue":"14","key":"2699_CR24","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/pros.20825","volume":"68","author":"YC Chen","year":"2008","unstructured":"Chen YC, Page JH, Chen R, Giovannucci E. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. Prostate. 2008;68(14):1582\u201391.","journal-title":"Prostate"},{"issue":"5","key":"2699_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/ijc.23591","volume":"123","author":"J Ahn","year":"2008","unstructured":"Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D. Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Int J Cancer. 2008;123(5):1154\u20139.","journal-title":"Int J Cancer"},{"issue":"6","key":"2699_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1055-9965.EPI-16-0801","volume":"26","author":"TP Ahern","year":"2017","unstructured":"Ahern TP, Sprague BL, Bissell MCS, et al. Family history of breast cancer, breast density, and breast cancer risk in a U.S. Breast cancer screening population. Cancer Epidemiol Biomarkers Prev. 2017;26(6):938\u201344.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2699_CR27","unstructured":"R Core Team. R: slanguage and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020. http:\/\/www.R-project.org\/."},{"issue":"4","key":"2699_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.21457","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250\u201381. https:\/\/doi.org\/10.3322\/caac.21457.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2699_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.6004\/jnccn.2018.0067","volume":"16","author":"D Provenzale","year":"2018","unstructured":"Provenzale D, Gupta S, Ahnen DJ, et al. NCCN guidelines insights: colorectal cancer screening Version. J Natl Compr Canc Netw. 2018;16(8):939\u201349. https:\/\/doi.org\/10.6004\/jnccn.2018.0067.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"2699_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu AL, U.S. Preventive Services Task Force. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement [published correction appears in Ann Intern Med. 2016 Mar 15;164(6):448]. Ann Intern Med. 2016;164(4):279\u201396. https:\/\/doi.org\/10.7326\/M15-2886.","journal-title":"Ann Intern Med."},{"issue":"15","key":"2699_CR31","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society [published correction appears in JAMA. 2016 Apr 5;315(13):1406]. JAMA. 2015;314(15):1599\u2013614. https:\/\/doi.org\/10.1001\/jama.2015.12783.","journal-title":"JAMA"},{"issue":"6","key":"2699_CR32","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/j.canep.2012.08.008","volume":"36","author":"PF Pinsky","year":"2012","unstructured":"Pinsky PF, Black A, Parnes HL, et al. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. Cancer Epidemiol. 2012;36(6):e401\u20136. https:\/\/doi.org\/10.1016\/j.canep.2012.08.008.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"2699_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jnci\/djr500","volume":"104","author":"GL Andriole","year":"2012","unstructured":"Andriole GL, Crawford ED, Grubb RL 3rd, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104(2):125\u201332. https:\/\/doi.org\/10.1093\/jnci\/djr500.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2699_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120\u201334. https:\/\/doi.org\/10.7326\/0003-4819-157-2-201207170-00459.","journal-title":"Ann Intern Med"},{"key":"2699_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fgene.2018.00624","volume":"9","author":"S Oliveri","year":"2018","unstructured":"Oliveri S, Ferrari F, Manfrinati A, Pravettoni G. A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases. Front Genet. 2018;9:624. https:\/\/doi.org\/10.3389\/fgene.2018.00624.","journal-title":"Front Genet"},{"key":"2699_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12875-016-0483-2","volume":"17","author":"M Paneque","year":"2016","unstructured":"Paneque M, Turchetti D, Jackson L, Lunt P, Houwink E, Skirton H. A systematic review of interventions to provide genetics education for primary care. BMC Fam Pract. 2016;17:89. https:\/\/doi.org\/10.1186\/s12875-016-0483-2.","journal-title":"BMC Fam Pract"},{"key":"2699_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","volume":"3","author":"LJ Esserman","year":"2017","unstructured":"Esserman LJ, WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017;3:34. https:\/\/doi.org\/10.1038\/s41523-017-0035-5.","journal-title":"NPJ Breast Cancer."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-020-02699-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T01:11:20Z","timestamp":1611277880000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2699"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02699-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-93488\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were recruited from an existing IRB-approved genomic study, called the Genomic Health Initiative at NorthShore University HealthSystem. All participants provided written informed consent to participate in the current study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}